«  
  »

Jazz Pharmaceuticals Provides Update On FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) In Fibromyalgia

By roy, on August 29th, 2010

Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that the Joint Advisory Committee of the U.S…

View full post on Fibromyalgia News From Medical News Today

Fibromyalgia   , , , , , , , , , ,  
«  
  »

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

«  
  »